150 related articles for article (PubMed ID: 37874924)
21. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
22. Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis.
Hsueh KC; Lee CC; Huang PT; Liang CY; Yang SF
Curr Oncol; 2023 Mar; 30(3):3206-3216. PubMed ID: 36975456
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the prognosis of BCLC stage A ruptured hepatocellular carcinoma patients after undergoing transarterial chemoembolization (TACE) or hepatectomy: a propensity score-matched landmark analysis.
Xia F; Zhang Q; Chen X; Zhang B; Ndhlovu E; Zhang M; Zhu P
Surg Endosc; 2022 Dec; 36(12):8992-9000. PubMed ID: 35920912
[TBL] [Abstract][Full Text] [Related]
24. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
[TBL] [Abstract][Full Text] [Related]
25. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
[No Abstract] [Full Text] [Related]
26. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
[TBL] [Abstract][Full Text] [Related]
27. New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study.
Iida H; Kaibori M; Hirokawa F; Inoue Y; Ueno M; Matsui K; Ishizaki M; Tanaka S; Takemura S; Nomi T; Hokutou D; Noda T; Eguchi H; Nakai T; Maehira H; Mori H; Tani M; Kubo S
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2903-2911. PubMed ID: 33112547
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
29. Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Zhu XD; Huang C; Shen YH; Xu B; Ge NL; Ji Y; Qu XD; Chen L; Chen Y; Li ML; Zhu JJ; Tang ZY; Zhou J; Fan J; Sun HC
Ann Surg Oncol; 2023 May; 30(5):2782-2790. PubMed ID: 36178565
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
31. Hepatectomy combined with sorafenib in patients with intermediate-advanced hepatocellullar carcinoma.
Zhu H; Ye B; Qiao Z; Zeng L; Li Q
J BUON; 2019; 24(4):1382-1389. PubMed ID: 31646781
[TBL] [Abstract][Full Text] [Related]
32. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
33. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
Wang X; Wang Z; Wu L
BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
[TBL] [Abstract][Full Text] [Related]
34. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
35. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
36. Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
Jin ZC; Zhong BY; Chen JJ; Zhu HD; Sun JH; Yin GW; Ge NJ; Luo B; Ding WB; Li WH; Chen L; Wang YQ; Zhu XL; Yang WZ; Li HL; Teng GJ;
Eur Radiol; 2023 Dec; 33(12):8669-8681. PubMed ID: 37368105
[TBL] [Abstract][Full Text] [Related]
37. Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
Kim H; Ahn SW; Hong SK; Yoon KC; Kim HS; Choi YR; Lee HW; Yi NJ; Lee KW; Suh KS;
Br J Surg; 2017 Jul; 104(8):1045-1052. PubMed ID: 28480964
[TBL] [Abstract][Full Text] [Related]
38. Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.
Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Itobayashi E; Nouso K; Kariyama K; Ishikawa T; Hirooka M; Hiasa Y
Cancer Sci; 2017 Jul; 108(7):1414-1420. PubMed ID: 28406546
[TBL] [Abstract][Full Text] [Related]
39. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
[TBL] [Abstract][Full Text] [Related]
40. Proposal for subclassification to select patients for hepatectomy with intermediate hepatocellular carcinoma and Child-Pugh A liver function: A double-center study from China.
Xu W; Rao Q; An Y; Li M; Xu G; Sang X; Lu X; Zhang Z; Mao Y
Medicine (Baltimore); 2018 Aug; 97(32):e11800. PubMed ID: 30095644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
